KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Tax Rate (2016 - 2026)

Pacira BioSciences has reported Tax Rate over the past 14 years, most recently at 41.66% for Q1 2026.

  • For Q1 2026, Tax Rate fell 307.0% year-over-year to 41.66%; the TTM value through Mar 2026 reached 60.98%, up 11343.0%, while the annual FY2025 figure was 58.31%, 11608.0% up from the prior year.
  • Tax Rate for Q1 2026 was 41.66% at Pacira BioSciences, up from 186.69% in the prior quarter.
  • Over five years, Tax Rate peaked at 133.49% in Q3 2022 and troughed at 186.69% in Q4 2025.
  • A 5-year average of 12.95% and a median of 34.17% in 2024 define the central range for Tax Rate.
  • Biggest five-year swings in Tax Rate: skyrocketed 10638bps in 2022 and later tumbled -22385bps in 2025.
  • Year by year, Tax Rate stood at 44.09% in 2022, then crashed by -40bps to 26.25% in 2023, then skyrocketed by 42bps to 37.16% in 2024, then tumbled by -602bps to 186.69% in 2025, then skyrocketed by 122bps to 41.66% in 2026.
  • Business Quant data shows Tax Rate for PCRX at 41.66% in Q1 2026, 186.69% in Q4 2025, and 42.97% in Q3 2025.